Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 100, Issue 3, 2013, Pages 385-390

  Li, Qin ^a,b   Gong, Wei ^b   Yang, Zhihong ^b   Lu, Bin ^b   Yang, Yehong ^b   Zhao, Weiwei ^b   Hu, Renming ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Angptl2; Nephropathy; Type 2 diabetes

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 2; GLUCOSE; UNCLASSIFIED DRUG;

AGE; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

AGED; ALBUMINURIA; ANGIOPOIETINS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84878486996     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.03.028     Document Type: Article

References (26)

1. Amos A.F., McCarty D.J., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14:S7-S85.
2. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861-869.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
4. Caramori M.L., Fioretto P., Mauer M. The need for early predictors of diabetic nephropathy risk - is albumin excretion rate sufficient?. Diabetes 2000, 49:1399-1408.
5. Chen H., Zheng Z., Li R., Lu J., Bao Y., Ying X., et al. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy. Am J Nephrol 2010, 32:47-56.
6. Doi Y., Ninomiya T., Hirakawa Y., Takahashi O., Mukai N., Hata J., et al. Angiopoietin-like protein 2 and risk of type 2 diabetes in a general japanese population: the hisayama study. Diabetes Care 2013, 36:98-100.
7. Dronavalli S., Duka I., Bakris G.L. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008, 4:444-452.
8. Keane W.F., Brenner B.M., de Zeeuw D., Grunfeld J.P., McGill J., Mitch W.E., et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 2003, 63:1499-1507.
9. Kim I., Moon S.O., Koh K.N., Kim H., Uhm C.S., Kwak H.J., et al. Molecular cloning, expression, and characterization of angiopoietin-related protein - Angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 1999, 274:26523-26528.
10. Kubota Y., Oike Y., Satoh S., Tabata Y., Niikura Y., Morisada T., et al. Cooperative interaction of angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acad Sci USA 2005, 102:13502-13507.
11. Lane P.H., Steffes M.W., Mauer S.M. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992, 41:581-586.
12. Lu B., Yang Z.H., Wang M., Yang Z., Gong W., Yang Y.H., et al. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2010, 88:289-294.
13. MacIsaac R.J., Panagiotopoulos S., McNeil K.J., Smith T.J., Tsalamandris C., Hao H.M., et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?. Diabetes Care 2006, 29:1560-1566.
14. Martin A., Komada M.R., Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003, 23:117-145.
15. Min W., Yamanaka N. Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Arch 1993, 423:201-207.
16. Mogensen C.E., Steffes M.W., Myers B.D., Viberti G., Friedman E.A., Deckert T., et al. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987, 31:673-689.
17. Molitch M.E., DeFronzo R.A., Franz M.J., Keane W.F., Mogensen C.E., Parving H.-H., et al. Nephropathy in diabetes. Diabetes Care 2004, 27(Suppl. 1):S79-S83.
18. Oike Y. Role of angiopoietin-like proteins (Angptls) in angiogenesis and metabolism. Regul Pept 2006, 135:108.
19. Okada T., Tsukano H., Endo M., Tabata M., Miyata K., Kadomatsu T., et al. Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 2010, 176:2309-2319.
20. W.H. Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation; 2006.
21. Sun H., Zheng J.M., Chen S., Zeng C.H., Liu Z.H., Li L.S. Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy. Nephron Exp Nephrol 2007, 105:E117-E123.
22. Tabaei B.P., Al-Kassab A.S., Ilag L.L., Zawacki C.M., Herman W.H. Does microalbuminuria predict diabetic nephropathy?. Diabetes Care 2001, 24:1560-1566.
23. Tabata M., Kadomatsu T., Fukuhara S., Miyata K., Ito Y., Endo M., et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009, 10:178-188.
24. Tsalamandris C., Allen T.J., Gilbert R.E., Sinha A., Panagiotopoulos S., Cooper M.E., et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 1994, 43:649-655.
25. Wehner H., Nelischer G. Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats. Virchows Arch 1991, 419:231-235.
26. Yamamoto Y., Maeshima Y., Kitayama H., Kitamura S., Takazawa Y., Sugiyama H., et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004, 53:1831-1840.